Company · CIK 2079109
Veraxa Biotech AG - Post de-SPAC
| CIK | 2079109 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | V8 |
| Listed | VRXA (Nasdaq), VRXAW (Nasdaq) |
| First annual or quarterly report | 2026-06-16 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-297907 | 2026-07-31 | 2026-08-10 | 4 | |
| 333-297908 | 2026-07-31 | 2026-08-10 | 4 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-10 | 424B5Shelf takedown | 333-297908 | 0001829126-26-008548 |
| 2026-08-10 | 424B5Shelf takedown | 333-297907 | 0001829126-26-008547 |
| 2026-08-06 | EFFECTDeclared effective | 333-297907 | 9999999995-26-002591 |
| 2026-08-06 | EFFECTDeclared effective | 333-297908 | 9999999995-26-002577 |
| 2026-08-05 | F-1/AAmendment | 333-297907 | 0001829126-26-008400 |
| 2026-08-05 | F-1/AAmendment | 333-297908 | 0001829126-26-008399 |
| 2026-07-31 | F-1Registration filed | 333-297908 | 0001829126-26-008247 |
| 2026-07-31 | F-1Registration filed | 333-297907 | 0001829126-26-008246 |
| 2026-02-17 | EFFECTDeclared effective | 333-289108 | 9999999995-26-000595 |